Good response of endogenous erythropoietin to blood loss in persistently improving renal anemia after discontinuation of erythropoietin treatment (letter)

Yabana M; Ikeda Y; Kihara M; Kurita K; Toya Y; Tamura K; Takagi N; Onishi T; Umemura S

首页> 外文期刊>Nephron >Good response of endogenous erythropoietin to blood loss in persistently improving renal anemia after discontinuation of erythropoietin treatment (letter)

【24h】

Good response of endogenous erythropoietin to blood loss in persistently improving renal anemia after discontinuation of erythropoietin treatment (letter)

机译：终止促红细胞生成素治疗后持续改善肾性贫血，内源性促红细胞生成素对失血的良好反应（字母）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Nephron》 |1999年第1期|共2页
作者
Yabana M; Ikeda Y; Kihara M; Kurita K; Toya Y; Tamura K; Takagi N; Onishi T; Umemura S;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类泌尿科学（泌尿生殖系疾病）;
关键词
Anemia; Erythropoietin; Erythropoietin; Recombinant; Kidney; Cystic; 贫血; 红细胞生成素; 红细胞生成素; 重组; 肾; 囊性;

机译：Anemia;Erythropoietin;Erythropoietin;Recombinant;Kidney;Cystic;贫血;红细胞生成素;红细胞生成素;重组;肾;囊性;

相似文献

外文文献
中文文献
专利

1. Good response of endogenous erythropoietin to blood loss in persistently improving renal anemia after discontinuation of erythropoietin treatment (letter) [J] . Yabana M, Ikeda Y, Kihara M, Nephron . 1999,第1期

机译：终止促红细胞生成素治疗后持续改善肾性贫血，内源性促红细胞生成素对失血的良好反应（字母）
2. The endogenous erythropoietin response and the erythropoietic response to blood loss anemia: the effects of age and gender. [J] . Goodnough LT, Price TH, Parvin CA The Journal of laboratory and clinical medicine . 1995,第1期

机译：对失血性贫血的内源性促红细胞生成素反应和促红细胞生成反应：年龄和性别的影响。
3. Neutrophil Gelatinase-Associated Lipocalin (NGAL) in Chronic Cardiorenal Failure is Correlated with Endogenous Erythropoietin Levels and Decreases in Response to Low-Dose Erythropoietin Treatment [J] . Emans M.E., Braam B., Diepenbroek A., Kidney and blood pressure research . 2012,第1期

机译：中性粒细胞明胶酶相关的脂蛋白（NGAL）在慢性心肾衰竭中与内源性促红细胞生成素水平相关，并且对低剂量促红细胞生成素治疗的反应降低
4. Rational Engineering of Targeted Erythropoietin for Treatment of Anemia [C] . Jungmin Lee, Katherine Redfield, Andyna Vernet, Protein Engineering Summit. . 2018

机译：靶向促红细胞生成素治疗贫血的理性工程
5. Pharmacokinetic and Pharmacodynamic Modeling of Recombinant Human Erythropoietin: The Basis for Improvement of Personalized Anemia Management [D] . Nguyen, Ly Minh. 2021

机译：重组人促红细胞生成素的药代动力学和药效模型：改进个性化贫血管理的基础
6. Evidence of Receptor-Mediated Elimination of Erythropoietin by Analysis of Erythropoietin Receptor mRNA Expression in Bone Marrow and Erythropoietin Clearance During Anemia [O] . Demet Nalbant, Mohammad Saleh, Frederic D. Goldman, -1

机译：贫血期间骨髓中促红细胞生成素受体mRNA表达和促红细胞生成素清除率的分析证明了受体介导的促红细胞生成素的消除
7. Neutrophil Gelatinase-Associated Lipocalin (NGAL) in Chronic Cardiorenal Failure is Correlated with Endogenous Erythropoietin Levels and Decreases in Response to Low-Dose Erythropoietin Treatment. [O] . Emans, M.E., Braam, B., Diepenbroek, A., 2012

机译：中性粒细胞明胶酶相关的脂蛋白（NGAL）在慢性心肾衰竭中与内源性促红细胞生成素水平相关，并且对低剂量促红细胞生成素治疗的反应降低。

Good response of endogenous erythropoietin to blood loss in persistently improving renal anemia after discontinuation of erythropoietin treatment (letter)

著录项

相似文献

相关主题

期刊订阅